中国肝癌早筛策略专家共识

2021-06-29 全国多中心前瞻性肝癌极早期预警筛查项目中华肝脏病杂志

原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。

中文标题：

中国肝癌早筛策略专家共识

发布机构：

全国多中心前瞻性肝癌极早期预警筛查项目

发布日期：

2021-06-29

简要介绍：

原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。全国多中心前瞻性肝癌极早期预警筛查项目(Prospective suRveillance for very Early hepatoCellular cARcinoma,PreCar)专家组基于国内外主要相关指南、临床实践和PreCar项目研究最新进展,提出了中国早期肝癌筛查策略和具体流程,旨在为早期肝癌筛查和诊断提供实际方法,提高我国防控水平。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=331791c002193e62, title=中国肝癌早筛策略专家共识, enTitle=, guiderFrom=中华肝脏病杂志, authorId=0, author=, summary=原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。, cover=https://img.medsci.cn/2021927/1632750868868_5579292.jpg, journalId=0, articlesId=null, associationId=1987, associationName=全国多中心前瞻性肝癌极早期预警筛查项目, associationIntro=全国多中心前瞻性肝癌极早期预警筛查项目(PreCar)专家组, copyright=0, guiderPublishedTime=Tue Jun 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。全国多中心前瞻性肝癌极早期预警筛查项目(Prospective suRveillance for very Early hepatoCellular cARcinoma,PreCar)专家组基于国内外主要相关指南、临床实践和PreCar项目研究最新进展,提出了中国早期肝癌筛查策略和具体流程,旨在为早期肝癌筛查和诊断提供实际方法,提高我国防控水平。 </span></p>, tagList=[TagDto(tagId=429, tagName=肝癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=429, guiderKeyword=肝癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5742, appHits=184, showAppHits=0, pcHits=1829, showPcHits=5558, likes=1, shares=6, comments=8, approvalStatus=1, publishedTime=Mon Sep 27 21:57:28 CST 2021, publishedTimeString=2021-06-29, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Sep 27 21:53:22 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 10:44:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国肝癌早筛策略专家共识.pdf)])

中国肝癌早筛策略专家共识.pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
2022-01-21 ms1000001107271726

学习了，真好

73 0
[GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
2021-12-20 ms5000000464933653

早筛早治疗

87 0
[GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
2021-11-02 燕子Yvonne

早诊早筛

88 0
[GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
2021-10-08 ms2000001690313017

好

100 0
[GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
2021-09-28 13f0c37dm61暂无昵称

好的很的文章，多多学习

113 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

中国肝癌早筛策略专家共识

相关指南

拓展阅读

科室

工具

服务